PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long-term varenicline treatment supports tobacco abstinence in people with mental illness

2014-01-08
(Press-News.org) Contact information: Kristen Chadwick
kschadwick@partners.org
617-643-3907
Massachusetts General Hospital
Long-term varenicline treatment supports tobacco abstinence in people with mental illness Extended treatment with the smoking cessation drug varenicline (Chantix) significantly improved the ability of individuals with serious mental illness to maintain abstinence from tobacco after a standard 12-week course of treatment. In this Massachusetts General Hospital (MGH) study – the first randomized, controlled trial of maintenance pharmacotherapy for smoking cessation in such patients – participants who quit smoking and then received varenicline along with cognitive behavioral therapy for an additional 40 weeks were three times more successful in maintaining abstinence from smoking than those who received cognitive behavioral therapy and a placebo drug.

"We know that relapsing to smoking is a big problem for smokers without psychiatric illness, but relapsing after a course of smoking cessation medication appears to happen even more rapidly in those with schizophrenia and related disorders," says Eden Evins, MD, MPH, director of the MGH Center for Addiction Medicine and lead author of the report in the Jan. 8 Journal of the American Medical Association. "Maintenance therapy to help these patients sustain abstinence could reduce an important source of stigma, along with their heavy burden of smoking-related illness."

The authors note that, although the rate of smoking among U.S. adults has dropped more than 50 percent since the mid-1960s, the current prevalence of smoking among those with serious mental illness is even higher than it was among the general population in 1965. Half of those who smoke and don't quit will die of a smoking-related illness. Although the majority of individuals with schizophrenia or bipolar disorder smoke tobacco, adults with serious mental illness are rarely offered even a 12-week course of smoking cessation medication. In fact, Evins notes, MassHealth – the Massachusetts Medicaid program – does not reimburse mental health care providers for behavioral smoking cessation treatment services.

One small, uncontrolled study conducted at MGH suggested that an additional 40 weeks of cessation medication treatment could significantly cut the relapse rate among those with serious mental illness. The current study was designed to carefully evaluate whether extended varenicline and cognitive behavioral therapy help maintain the success of patients who achieve abstinence after an initial 12-week cessation program. Participants currently being treated for schizophrenia, for a related condition called schizoaffective disorder, or bipolar disorder enrolled in the study at 10 mental health centers in six states.

After the initial 12-week cessation phase, during which all participants received daily doses of varenicline and weekly group cognitive behavioral therapy sessions, 87 of the original 203 participants (42 percent) were considered to be abstinent. Those individuals were randomized to either continued varenicline or a placebo during the 40-week relapse prevention phase. Both groups continued to receive cognitive behavioral therapy on a schedule of declining frequency during the prevention phase, at the end of which all smoking cessation therapies were discontinued.

At the end of the yearlong study period, 60 percent of participants who received varenicline during the relapse prevention phase were abstinent, based on both self-reporting and on measured levels of exhaled carbon monoxide. Only 19 percent of the placebo group were abstinent at this point. While half of those in the placebo group had relapsed within 35 days of discontinuing varenicline, it took almost a year for half of those in the varenicline group to relapse. Although continued cognitive behavioral therapy was not enough to prevent relapse in the placebo group, the fact that those in the varenicline group who did relapse tended to do so after cognitive behavioral therapy was reduced to a monthly schedule suggests that it may have a role in supporting the benefits of drug therapy.

"Our study showed that cognitive behavioral therapy alone is not enough to help smokers with serious mental illness maintain the abstinence they achieved with a program combining both therapies," Evins explains. "Since we don't know yet how well varenicline would work without cognitive behavioral therapy, we would recommend that these patients be offered both therapies together to support smoking cessation and continued abstinence. Additional studies are needed to evaluate combinations of pharmacotherapy with less intensive behavioral support – like telephone quit lines – and to determine whether other smoking cessation drugs like bupropion would work as well for maintenance treatment."

INFORMATION:

Evins is an associate professor of Psychiatry at Harvard Medical School. Additional co-authors of the JAMA report are Corinne Cather, PhD, Gladys Pachas, MD, and Susanne Hoeppner, PhD, MGH Psychiatry; David Schoenfeld, PhD, MGH Biostatistics; Sarah Pratt, PhD, Geisel School of Medicine, Dartmouth College; Donald Goff, MD, New York University Langone Medical Center; Eric Achtyes, MD, MD, Michigan State University School of Human Medicine; and David Ayer, PhD, Indiana University. Support for the study includes National Institute of Drug Abuse grants RO1 DA021245 and K24 DA030443.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

END



ELSE PRESS RELEASES FROM THIS DATE:

BPA increases risk of cancer in human prostate tissue

2014-01-08
BPA increases risk of cancer in human prostate tissue Fetal exposure to a commonly used plasticizer found in products such as water bottles, soup can liners and paper receipts, can increase the risk for prostate cancer later in life, according to a study from ...

Study estimates tobacco control in US has saved 8 million lives in last 50 years

2014-01-08
Study estimates tobacco control in US has saved 8 million lives in last 50 years Researchers estimate that tobacco control in the U.S. since 1964 has been associated with the avoidance of an estimated 8 million premature smoking-attributable deaths, with the ...

Overall prevalence of smoking has decreased globally, although number of smokers has increased

2014-01-08
Overall prevalence of smoking has decreased globally, although number of smokers has increased Since 1980, the global prevalence of daily tobacco smoking has declined by an estimated 25 percent for men and 42 percent for women, although because of population growth, ...

Adults with mental illness have lower rate of decline in smoking

2014-01-08
Adults with mental illness have lower rate of decline in smoking In recent years, the decline in smoking among individuals with mental illness was significantly less than among those without mental illness, although the rates of quitting smoking were greater ...

Combination therapy does not improve ability to quit smoking after 1 year

2014-01-08
Combination therapy does not improve ability to quit smoking after 1 year Among cigarette smokers, the combined use of the smoking cessation medications varenicline and bupropion, compared with varenicline alone, resulted in better rates of smoking abstinence ...

Longer-term use of smoking cessation medication effective among patients with mental illness

2014-01-08
Longer-term use of smoking cessation medication effective among patients with mental illness Among smokers with schizophrenia or bipolar disease who achieved initial smoking abstinence with a standard 12-week course of the smoking cessation drug varenicline, an additional ...

Study examines prevalence of smoking among health care professionals

2014-01-08
Study examines prevalence of smoking among health care professionals A survey of health care professionals finds that in 2010-2011, current smoking among this group, except for licensed practical nurses, was lower than the general population, and that the majority ...

Unique protein interaction may drive most common genetic cause of Parkinson's disease

2014-01-08
Unique protein interaction may drive most common genetic cause of Parkinson's disease Gladstone findings challenge conventional wisdom; point to new therapeutic strategies San Francisco, CA—January 7, 2013—The most devastating aspect of Parkinson's disease ...

Survival protein a potential new target for many cancers

2014-01-08
Survival protein a potential new target for many cancers Walter and Eliza Hall Institute researchers have discovered a promising strategy for treating cancers that are caused by one of the most common cancer-causing changes in cells. The discovery offers ...

Fit teenagers are less likely to have heart attacks in later life

2014-01-08
Fit teenagers are less likely to have heart attacks in later life Researchers in Sweden have found an association between a person's fitness as a teenager and their risk of heart attack in later life. In a study of nearly 750,000 men, they found that the more aerobically ...

LAST 30 PRESS RELEASES:

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

[Press-News.org] Long-term varenicline treatment supports tobacco abstinence in people with mental illness